The Neuroimmune Institute, in collaboration with the Wisconsin Medical Society,
cordially invites you to attend:
IMPROVING QUALITY OF LIFE IN PATIENTS WITH AUTISM:
EMERGING RESEARCH, EVALUATION, AND MANAGEMENT
OF CO-OCCURRING CONDITIONS
Join us for a live virtual CME conference via Zoom webinar.
March 1 - 2, 2024
Most interventions for individuals with autism are focused on improving social skills, speech and language, addressing sensory and motor concerns, teaching self-care and daily living skills, and behavior management. Difficulty with communication, unusual presentation of symptoms, diagnostic overshadowing, and the tendency to view behaviors through the lens of “just autism” frequently lead to treatable medical comorbidities being overlooked.
The focus of this virtual conference is improving the quality of life in individuals with autism by educating physicians on medical comorbidities that are either more difficult to diagnose in autistic individuals or over-represented in individuals with autism compared to the general population as well as providing an overview of emerging research.
This conference features nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who will present a diverse range of clinical insights as well as emerging research. Presentations are carefully selected to familiarize attendees with developing research and to educate clinicians on diagnosis and treatment of co-occurring conditions in patients with autism.
Both generalists as well as specialists in pediatric and adult medicine will find the conference valuable to their practices. The intended audience is pediatricians, family physicians, gastroenterologists, psychiatrists, rheumatologists, immunologists, neurologists, and infectious disease physicians. Though the conference is designed for physicians, all are welcome to attend.
The virtual conference is being offered free of charge to 500 physicians
who have not attended a prior Neuroimmune event.
The link to register and request the fee be waived can be found on Neuroimmune Institute's website.
For questions, please email email@example.com